A novel inflammatory endotype diagnostic model based on cytokines in chronic rhinosinusitis with nasal polyps

被引:2
|
作者
Chen, Mengyu [1 ,2 ,3 ]
Xu, Zhaofeng [1 ,2 ,3 ]
Fu, Yiwei [4 ,7 ]
Zhang, Nan [1 ,2 ,3 ,5 ]
Lu, Tong [1 ,2 ,3 ]
Li, Zhengqi [1 ,2 ,3 ]
Li, Jian [1 ,2 ,3 ]
Bachert, Claus [1 ,2 ,3 ,5 ,9 ]
Wen, Weiping [1 ,2 ,3 ,6 ,8 ]
Wen, Yihui [1 ,2 ,3 ,8 ]
机构
[1] Sun Yat sen Univ, Affiliated Hosp 1, Dept Otolaryngol, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat sen Univ, Otorhinolaryngol Inst, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat sen Univ, Affiliated Hosp 1, Int Airway Res Ctr, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Musculoskeletal Oncol, Guangzhou, Peoples R China
[5] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium
[6] Sun Yat sen Univ, Affiliated Hosp 6, Dept Otolaryngol, Guangzhou, Guangdong, Peoples R China
[7] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[8] Sun Yat sen Univ, Affiliated Hosp 1, Dept Otolaryngol, 58 Zhong Shan Er Lu, Guangzhou 510000, Guangdong, Peoples R China
[9] Sun Yat sen Univ, Affiliated Hosp 1, Int Airway Res Ctr, 58 Zhong Shan Er Lu, Guangzhou 510000, Guangdong, Peoples R China
来源
WORLD ALLERGY ORGANIZATION JOURNAL | 2023年 / 16卷 / 07期
基金
中国国家自然科学基金;
关键词
AIRWAY INFLAMMATION; EUROPE;
D O I
10.1016/j.waojou.2023.100796
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background:Type 2 CRSwNP is characterized by severe symptoms, multiple comorbidities, longer recovery course and high recurrence rate. A simple and cost-effective diagnostic model for CRSwNP endotype integrating clinical characteristics and histopathological features is urgently needed. Objective:To establish a clinical diagnostic model of inflammatory endotype in CRSwNP based on the clinical characteristics, pathological characteristics, and cytokines profile in the polyp tissue of patients. Methods:A total of 244 participants with CRSwNP were enrolled at 2 different centers in China and Belgium from 2018 to 2020. IL-5 level of nasal polyp tissue was used as gold standard. Clinical characteristics were used to establish diagnostic models. The area under the receiver operating curve (AUC) was used to evaluate the diagnostic performance. The study was approved by the ethics board of the First Affiliated Hospital of Sun Yat-sen University ([2020] 302), and written informed consent was obtained from all subjects before inclusion. Results:In total, 134 patients from China (training set) and 110 patients from Belgium (validation set) were included. The logistic regression (LR) model in predicting inflammatory endotype of CRSwNP showed the AUC of 83%, which was better than the diagnostic performance of machine learning models (AUC of 61.14%-82.42%), and single clinical variables. We developed a simplified scoring system based on LR model which shows similar diagnostic performance to the LR model Conclusion:The LR model in this diagnostic study provided greater accuracy in prediction of inflammatory endotype of CRSwNP than those obtained from the machine learning model and single clinical variable. This indicates great potential for the use of diagnostic model to facilitate inflammatory endotype evaluation when tissue cytokines are unable to be measured.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] A classification of chronic rhinosinusitis with nasal polyps based on structured histopathology
    Brescia, Giuseppe
    Alessandrini, Lara
    Giacomelli, Luciano
    Parrino, Daniela
    Zanotti, Claudia
    Tealdo, Giulia
    Franz, Leonardo
    Carraro, Valentina
    Barion, Umberto
    Marioni, Gino
    HISTOPATHOLOGY, 2020, 76 (02) : 296 - 307
  • [42] Antibody-based therapeutics for chronic rhinosinusitis with nasal polyps
    Shishodia, Shama
    Haloob, Nora
    Hopkins, Claire
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (06) : 491 - 502
  • [43] Evidence-based treatment of chronic rhinosinusitis with nasal polyps
    Schlosser, Rodney J.
    Soler, Zachary M.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2013, 27 (06) : 461 - 466
  • [44] Diagnostic value and underlying mechanism of nasal nitric oxide in eosinophilic chronic rhinosinusitis with nasal polyps
    Tang, Binxiang
    Tu, Junhao
    Zhang, Meiping
    Zhang, Zhiqiang
    Yu, Jieqing
    Shen, Li
    Luo, Qing
    Ye, Jing
    MOLECULAR IMMUNOLOGY, 2023, 159 : 1 - 14
  • [46] Identification of Inflammatory Endotypes by Clinical Characteristics and Nasal Secretion Biomarkers in Chronic Rhinosinusitis with Nasal Polyps
    Guo, Cui-Lian
    Lu, Ruo-Yu
    Wang, Chong-Shu
    Zhao, Jie-Fang
    Pan, Li
    Liu, Hui-Cheng
    Liao, Bo
    Liu, Zheng
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) : 955 - 965
  • [47] An Integrated Analysis of Inflammatory Endotypes and Clinical Characteristics in Chronic Rhinosinusitis with Nasal Polyps
    Hao, Dingqian
    Wu, Yisha
    Li, Ping
    Li, Chunhao
    Jiang, Tianjiao
    Zhang, Qian
    Liu, Shengyang
    Shi, Li
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 5557 - 5565
  • [48] Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis
    Ryu, Gwanghui
    Kim, Dae Woo
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 20 (01) : 1 - 8
  • [49] Local inflammatory marker production in Lithuanian patients with chronic rhinosinusitis with nasal polyps
    Vaitkus, Justinas
    Vitkauskiene, Astra
    Matuseviciute, Vilte
    Naudziunas, Albinas
    Siupsinskiene, Nora
    Vaitkus, Saulius
    JOURNAL OF IMMUNOTOXICOLOGY, 2020, 17 (01) : 202 - 206
  • [50] Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois
    Tan, Bruce K.
    Klingler, Aiko I.
    Poposki, Julie A.
    Stevens, Whitney W.
    Peters, Anju T.
    Suh, Lydia A.
    Norton, James
    Carter, Roderick G.
    Hulse, Kathryn E.
    Harris, Kathleen E.
    Grammer, Leslie C.
    Schleimer, Robert P.
    Welch, Kevin C.
    Smith, Stephanie S.
    Conley, David B.
    Kern, Robert C.
    Kato, Atsushi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : 699 - +